Evommune, Inc.

NYSE:EVMN

Biotechnology

Healthcare
$7.02 -0.82%

-$0.17 today

Market cap
$290.28M
Beta
0.10
P/E (TTM)
-9.1
EPS (TTM)
-$2.26
52W Low $13.89High $33.20

Volume 0.90M

Average 0.38M

Income Statement

Follow revenue through to earnings.

Revenue

$13.00M

FY 2025 · Annual

+85.7% YoY

Operating Income

-$81.07M

FY 2025 · Annual

Net Income

-$68.87M

FY 2025 · Annual

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5M7M13M
Cost of Revenue1M1.29M0
Gross Profit4M5.71M13M
Gross Margin80.0%81.6%100.0%
Research & Development32M64.24M74.04M
Selling, General & Admin9.85M11.48M20.03M
Operating Expenses41.85M75.73M94.07M
Depreciation & Amortization1M1.29M1.39M
EBITDA(33M)(65.49M)(67.48M)
EBITDA Margin-659.9%-935.5%-519.1%
Operating Income(37.85M)(70.01M)(81.07M)
Operating Margin-757.0%-1000.2%-623.6%
Interest Income3.86M3.24M3.32M
Interest Expense58K34K0
Other Income / Expenses3.8M3.2M12.2M
Income Before Tax(34.05M)(66.81M)(68.87M)
Pre-Tax Margin-681.1%-954.4%-529.8%
Income Tax Expense000
Net Income(34.05M)(66.81M)(68.87M)
Net Margin-681.1%-954.4%-529.8%
EPS (Basic)(1.13)(2.27)(2.18)
EPS (Diluted)(1.13)(2.27)(2.18)
Weighted Avg Shares30.08M30.08M31.52M
Weighted Avg Shares (Diluted)30.08M30.08M31.52M

EVMN Earnings Waterfall · TTM

NYSE:EVMN · Revenue to Net Income

Key Ratios

EPS$-2.39
Gross Margin25.0%
Net Margin-31.2%
P/E Ratio-9.4
P/S Ratio15.9

Analysis

$10.0M of revenue converted into -$76.0M of net income for the selected period. Gross margin is 25.0% and net margin is -31.2%, showing how much revenue survives after costs and taxes. EPS is $-2.39, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
424B3424B3 filingNov 12, 2026
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
SC 13D/ASC 13D/A filingNov 10, 2026
8-KCurrent reportNov 5, 2026

How much revenue does EVMN generate?

Evommune, Inc. (EVMN) reported $13.00M of revenue in fiscal 2025.

Is EVMN profitable?

Evommune, Inc. (EVMN) reported -$68.87M of net income, with a net margin of -529.8%.